INDIA LIVE DESKNIFTY 50:23,140.50(+0.34%)SENSEX:73,895.74(+0.43%)
RDU Global
🇮🇳
Home/Topics/Companies & Institutions/Indian pharmaceutical industry
Back to Newsroom
🏢Organization Dossier

Indian pharmaceutical industry

Curated news coverage, institutional background, regulatory filings, and investigative reporting across RDU Global.

10 Stories Indexed
Last Updated: Just Now
Verified Entity Intelligence
Healthcare, Pharma & Life Sciences 05 Nov 2026, 08:00 PM IST

India Moves to Suspend Drug Manufacturing Licences Immediately Over Quality Failures

India is proposing a tougher regulatory regime that would allow authorities to suspend drug manufacturing licences immediately when quality failures are detected, a move aimed at preventing substandard medicines from remaining in circulation while manufacturers correct deficiencies. The proposal signals a sharper enforcement posture in one of the world’s largest pharmaceutical markets, where quality lapses can quickly become a public health and export credibility issue.

By RDU Global Wire5 min read
Healthcare, Pharma & Life SciencesJust now (04:41 AM IST)

US Exempts Select Indian Specialty Drugs From 100% Tariff, Easing Pressure on Pharma Trade

The United States has exempted select Indian specialty drugs from a proposed 100% tariff, a move that should blunt immediate cost pressure on a critical export segment for India’s pharmaceutical industry. The decision offers relief to manufacturers of high-value medicines while underscoring the continuing sensitivity of trade policy in a sector central to both countries’ healthcare supply chains.

6 min readRead →
Macro Economy & Fiscal Policy27 Oct 2026, 08:00 PM IST

Cipla Q2 Profit Drops 35% to Rs 878 Crore as North America Weakness Weighs on Revenue

Cipla reported a sharp 35% year-on-year decline in second-quarter net profit to Rs 878 crore, as weaker North American sales and softer operating performance dragged on earnings. Revenue fell 2% and EBITDA also declined, even as the company posted 12% growth in India and highlighted regulatory progress and a biosimilar partnership to support its pipeline.

5 min readRead →
National Governance & Policy18 Oct 2026, 08:00 AM IST

India Says U.S. Trade Pact Drafting Under Way, Will Move Only When Competitive Gains Are Clear

India’s Commerce Minister Piyush Goyal said legal drafting is under way for a prospective trade agreement with the United States, but stressed that the pact will be operationalised only when India secures a clear competitive advantage. His remarks come as Commerce Secretary Rajesh Agrawal said negotiations are moving in the right direction, signalling cautious progress without a formal breakthrough.

5 min readRead →
National Governance & Policy15 Oct 2026, 05:03 PM IST

India-U.S. Trade Pact Will Move Forward Only When New Delhi Gains a Competitive Edge, Goyal Says

India will operationalise a trade pact with the United States only when it secures a competitive advantage, Commerce and Industry Minister Piyush Goyal said, signalling that New Delhi intends to negotiate from a position of economic leverage rather than urgency. His remarks come as India also prepares to conclude a free trade agreement with the European Union in December, with implementation expected by February or March next year.

6 min readRead →
National Governance & Policy15 Oct 2026, 04:42 PM IST

India Seeks to Rebuild China Ties, but Final Script Is Still Unwritten: Goyal

India is working to rebuild its relationship with China, but the process remains incomplete and the final outcome is still uncertain, Commerce and Industry Minister Piyush Goyal said on Wednesday. He also underscored that India’s ties with the United States remain strong and consequential, reflecting New Delhi’s effort to balance major-power relationships while protecting its economic and strategic interests.

5 min readRead →
Macro Economy & Fiscal Policy14 Oct 2026, 01:25 PM IST

Telangana Targets $1 Trillion Economy by 2034 as Growth Momentum Builds

Telangana is aiming to expand its economy to $1 trillion by 2034, according to an official statement that underscores the state’s long-term growth ambitions. With an estimated current gross state domestic product of about $200 billion and average growth of 10.75%, the target would require sustained expansion, deeper industrialisation and continued investment inflows over the next decade.

5 min readRead →
Macro Economy & Fiscal Policy13 Oct 2026, 09:53 AM IST

Corrugated Box Makers Face Margin Squeeze as Kraft Paper, Freight and Input Costs Surge

India’s corrugated box manufacturers are confronting a sharp cost shock as kraft paper prices jump 25% to 35%, driven by imported fibre constraints, geopolitical disruptions and higher input and freight costs. Industry players say delayed customer price revisions are intensifying margin pressure, leaving packaging firms with limited room to absorb the increase.

5 min readRead →
Macro Economy & Fiscal Policy13 Oct 2026, 02:01 AM IST

Astra Microwave, Manappuram Among Five Stocks Analysts Flag for Tuesday on Breakout Signals

Analysts have identified five stocks for Tuesday’s trade, including Astra Microwave, Manappuram Finance and Laurus Labs, on the back of bullish chart structures, improving momentum and breakout confirmations. The calls come as traders look for short-term opportunities in a market still driven by stock-specific action rather than broad directional conviction.

5 min readRead →
National Governance & Policy12 Oct 2026, 11:38 PM IST

Piyush Goyal Urges India, UK to Double Bilateral Trade by 2030

Commerce and Industry Minister Piyush Goyal has called for a sharp expansion in India-UK economic ties, setting a clear ambition to double bilateral trade by 2030. The push comes as New Delhi seeks to deepen market access, attract investment, and convert a long-discussed partnership into measurable commercial gains.

5 min readRead →

🏢 About this Entity

Corporations, startups, regulatory bodies, central banks, ministries and judicial courts. All news mentioning this entity is automatically verified and aggregated into this live intelligence dossier.

Co-Occurring Entities

Entities frequently referenced alongside Indian pharmaceutical industry: